No Data
Express News | The well-known European activist investment firm Bluebell is shutting down its hedge fund.
The Committee For Medicinal Products For Human Use Of The European Medicines Agency Has Recommended Expanding The Approval Of GSK's Jemperli (Dostarlimab) In Combination With Chemotherapy (Carboplatin And Paclitaxel) For First-line Treatment For...
GSK Passes Three Significant Milestones With New Cancer Drug Given a Double Boost | LSE:GSK, NYSE:GSK
GSK's Rectal Cancer Treatment Receives Breakthrough Designation From US FDA
GSK's Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission
Jemperli (Dostarlimab) Plus Chemotherapy Receives Positive CHMP Opinion to Expand Approval to All Adult Patients With Primary Advanced or Recurrent Endometrial Cancer